CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 42 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 4.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,493 | +12.7% | 2,549,134 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $14,629 | +64.2% | 2,363,211 | +2.2% | 0.00% | +100.0% |
| Q1 2023 | $8,907 | +20.4% | 2,313,433 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $7,400 | -99.9% | 2,387,167 | -2.4% | 0.00% | -50.0% |
| Q3 2022 | $9,833,000 | -18.0% | 2,445,983 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $11,986,000 | -47.2% | 2,461,130 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $22,681,000 | -3.0% | 2,528,583 | +21.8% | 0.00% | 0.0% |
| Q4 2021 | $23,384,000 | -29.3% | 2,076,770 | +2.9% | 0.00% | -33.3% |
| Q3 2021 | $33,091,000 | -24.5% | 2,017,873 | +0.3% | 0.00% | -25.0% |
| Q2 2021 | $43,858,000 | – | 2,011,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $299,329,000 | 65.12% |
| Vida Ventures Advisors, LLC | 3,931,818 | $65,661,000 | 18.81% |
| Samsara BioCapital, LLC | 1,537,533 | $25,677,000 | 4.03% |
| VR Adviser, LLC | 1,127,272 | $18,825,000 | 2.42% |
| Logos Global Management LP | 1,069,545 | $17,861,000 | 1.29% |
| Cormorant Asset Management, LP | 1,727,273 | $28,724,000 | 1.17% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $161,686,000 | 0.95% |
| Affinity Asset Advisors, LLC | 203,183 | $3,393,000 | 0.86% |
| RA Capital Management | 3,577,094 | $59,737,000 | 0.83% |
| Boxer Capital, LLC | 1,334,227 | $22,282,000 | 0.78% |